Follow
Elizabeth A Kuczynski
Elizabeth A Kuczynski
Unknown affiliation
Verified email at utoronto.ca
Title
Cited by
Cited by
Year
Vessel co-option in cancer
EA Kuczynski, PB Vermeulen, F Pezzella, RS Kerbel, AR Reynolds
Nature reviews Clinical oncology 16 (8), 469-493, 2019
3522019
Drug rechallenge and treatment beyond progression—implications for drug resistance
EA Kuczynski, DJ Sargent, A Grothey, RS Kerbel
Nature reviews Clinical oncology 10 (10), 571-587, 2013
2662013
Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models
VL Bridgeman, PB Vermeulen, S Foo, A Bilecz, F Daley, E Kostaras, ...
The Journal of pathology 241 (3), 362-374, 2017
1922017
Co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcinoma
EA Kuczynski, M Yin, A Bar-Zion, CR Lee, H Butz, S Man, F Daley, ...
Journal of the National Cancer Institute 108 (8), djw030, 2016
1642016
Non-angiogenic tumours and their influence on cancer biology
T Donnem, AR Reynolds, EA Kuczynski, K Gatter, PB Vermeulen, ...
Nature Reviews Cancer 18 (5), 323-336, 2018
1382018
Vessel co-option and resistance to anti-angiogenic therapy
EA Kuczynski, AR Reynolds
Angiogenesis 23 (1), 55-74, 2020
922020
Effects of sorafenib dose on acquired reversible resistance and toxicity in hepatocellular carcinoma
EA Kuczynski, CR Lee, S Man, E Chen, RS Kerbel
Cancer research 75 (12), 2510-2519, 2015
832015
Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitro
M Jarad, EA Kuczynski, J Morrison, AM Viloria-Petit, BL Coomber
BMC cell biology 18, 1-10, 2017
622017
Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity
S Langdon, A Hughes, MA Taylor, EA Kuczynski, DA Mele, O Delpuech, ...
Oncoimmunology 7 (8), e1458810, 2018
472018
VEGFR2 expression and TGF-β signaling in initial and recurrent high-grade human glioma
EA Kuczynski, SG Patten, BL Coomber
Oncology 81 (2), 126-134, 2011
392011
Feline programmed death and its ligand: characterization and changes with feline immunodeficiency virus infection
A Folkl, X Wen, E Kuczynski, ME Clark, D Bienzle
Veterinary immunology and immunopathology 134 (1-2), 107-114, 2010
372010
Impact of chemical-induced mutational load increase on immune checkpoint therapy in poorly responsive murine tumors
EA Kuczynski, J Krueger, A Chow, P Xu, S Man, Y Sundaravadanam, ...
Molecular cancer therapeutics 17 (4), 869-882, 2018
282018
Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma
EA Kuczynski, RS Kerbel
Chinese Journal of Cancer 35, 1-4, 2016
262016
Colorectal carcinoma cell production of transforming growth factor beta decreases expression of endothelial cell vascular endothelial growth factor receptor 2
EA Kuczynski, AM Viloria‐Petit, BL Coomber
Cancer 117 (24), 5601-5611, 2011
182011
Longitudinal tracking of T cell lymphomas in mice using flow cytometry
EA Kuczynski, L Carnevalli, C Sinclair
STAR protocols 4 (2), 102144, 2023
22023
AZD0171 (anti-LIF) combines productively with chemotherapy and anti-PD-L1 in mouse models of cancer
J Candido, G Kar, B Zhang, G Opoku-Ansah, A Grover, EA Kuczynski, ...
Cancer Research 82 (12_Supplement), 1293-1293, 2022
22022
A preclinical model of peripheral T‐cell lymphoma GATA3 reveals DNA damage response pathway vulnerability
EA Kuczynski, G Morlino, A Peter, AML Coenen‐Stass, JI Moss, N Wali, ...
EMBO Molecular Medicine 14 (6), e15816, 2022
22022
Mechanisms of reversible sorafenib resistance in hepatocellular carcinoma
EA Kuczynski
University of Toronto (Canada), 2016
12016
Abstract PO-20: Molecular characterization of a mouse model of peripheral T-cell lymphoma with Tfh and Th2 features
E Kuczynski, G Morlino, A Peter, D Calado, C Sinclair, L Carnevalli
Blood Cancer Discovery 1 (3_Supplement), PO-20-PO-20, 2020
2020
薬剤の再投与と増悪後の継続投与: 薬剤耐性の重要性
EA Kuczynski, DJ Sargent, A Grothey
Nature reviews. Cancer, clinical oncology 4 (1), 16-33, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–20